# Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy

> **NCT01000246** · NA · COMPLETED · sponsor: **St. Antonius Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Mamma Carcinoma
- Heart Failure

## Interventions

- **BIOLOGICAL:** influenza virus vaccine (influvac or vaxigrip)

## Key facts

- **NCT ID:** NCT01000246
- **Lead sponsor:** St. Antonius Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01000246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01000246, "Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01000246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*